-
Glucose-Dependent Insulinotropic Polypeptide Is Involved in Postprandial Regulation of Splanchnic Blood Supply Diabetes (IF 6.2) Pub Date : 2025-05-30
Rasmus S. Rasmussen, Ludvig S. Langberg, Frederikke Østergaard, Sophie W. Nielsen, Mark B. Vestergaard, Kirsa Skov-Jeppesen, Bolette Hartmann, Helle Hjorth Johannesen, Jens J. Holst, Bryan Haddock, Henrik B. W. Larsson, Mette M. Rosenkilde, Ali Asmar, Ulrik B. Andersen, Lærke S. GasbjergGastrointestinal hormones are essential for nutrient handling and regulation of glucose metabolism and may affect postprandial blood redistribution. In a randomized cross-over design in 10 healthy men, the involvement of glucose-dependent insulinotropic polypeptide (GIP) in splanchnic blood flow regulation was investigated using an infusion of GIP receptor antagonist (GIPR-An) GIP(3-30)NH2 during ingestion
-
Splanchnic and Leg Glucagon Metabolism in Healthy and Type 1 Diabetes: First in Human Study Using [13C9, 15N1]-Glucagon Diabetes (IF 6.2) Pub Date : 2025-05-30
F.N.U. Ruchi, Michele Schiavon, Yogesh Yadav, Chiara Dalla Man, Claudio Cobelli, Akhilesh Pandey, Luke Wilkins, Rita Basu, Ananda BasuCirculating glucagon concentrations differ between individuals with no diabetes (ND) and those with type 1 diabetes (T1D). We combined isotope dilution technique using stable tracers [6,22 13C9, 15N1]-glucagon and [6,14,19,22 13C9, 15N1]-glucagon with splanchnic and leg catheterization in participants with ND (n = 8; age 23.1 ± 2.9 years, BMI 26.6 ± 3.5 kg/m2, HbA1c 5.0 ± 0.2% [31 ± 2 mmol/mol]) and
-
Intrasplenic Transplantation of Islets With a Platelet-Shielding System Restores Glycemic Control Diabetes (IF 6.2) Pub Date : 2025-05-30
Lin Song, Chunyan Liu, Anqi Yang, Xiaohai Zhang, Xintong Wang, Yanjiao Teng, Decheng Lu, Xiaocong Kuang, Chunming Wang, Junfeng Zhang, Xuyong Sun, Lei DongIntraportal islet transplantation to treat insulin-dependent diabetes has been clinically validated. However, the hypoxic environment and sinusoidal architecture of the liver are unsuitable for the long-term survival of transplanted islets, leading to the loss of therapeutic effects within 1 year. The spleen has oxygen levels that meet islet needs, but intense instant blood-mediated inflammatory reactions
-
Codelivery of NGFR100W and VEGFA mRNA Enhances Vascular and Neural Repair in Diabetic Peripheral Neuropathy Diabetes (IF 6.2) Pub Date : 2025-05-28
Wenjing Wang, Xiang Yu, Zheng Yang, Yu Zhang, Wen Yang, Yingjie Xu, Wei XuDiabetic peripheral neuropathy (DPN) poses significant clinical challenges due to progressive nerve degeneration and vascular insufficiency. To address both neural and vascular complications simultaneously, we employed an mRNA-based protein replacement therapy. In this study, leveraging mRNA template design, structure-based screening identified NGFR100W as a variant dissociating neuroprotective and
-
Smaller Pancreas Volume in Insulin-Dependent Monogenic Diabetes Diabetes (IF 6.2) Pub Date : 2025-05-22
Jonathan M. Williams, Melissa A. Hilmes, Lisa R. Letourneau-Freiberg, Balamurugan Kandasamy, Demetra Braun, Siri Atma W. Greeley, Louis Philipson, Alvin C. Powers, John Virostko, Daniel J. Moore, Jordan J. WrightIndividuals with type 1 diabetes (T1D) or permanent neonatal diabetes (PND) due to an INS gene mutation (INS-PND) have a marked reduction in pancreas volume by MRI compared with control individuals with no diabetes (ND). One possible explanation for this is loss of islet-acinar insulin signaling in these forms of severe insulin deficiency. To test the hypothesis that insulin deficiency drives the loss
-
A functional and mechanistic explanation for the unique clinical success of the glucokinase activator dorzagliatin for treatment of type 2 diabetes Diabetes (IF 6.2) Pub Date : 2025-05-07
Jeff Roman, Yue Yuan, Yue Xu, Qiusha Zhu, Shaowen Wu, Fang Zhao, Xue Zhou, Shi Meng, Dongna Han, Kim Sharp, Li Chen, Changhong Li, Nicolai M DolibaGlucokinase activators (GKA) are a long-sought therapeutic modality for the treatment of Type 2 Diabetes (T2D). However, all GKAs failed clinical trials, with the recent exception of dorzagliatin (Hua Medicine). A comprehensive approach using human islet perfusions, enzyme kinetics, x-ray crystallography, and modeling studies was applied to compare the effects of dorzagliatin with the failed GKA MK-0941
-
Paradoxical Maturity-Onset Diabetes of the Young Arising From Loss-of-Function Mutations in ATP-Sensitive Potassium Channels Diabetes (IF 6.2) Pub Date : 2025-05-07
Rosa Scala, Yunpeng Li, Jian Gao, Nathan W. York, Ranjit Unnikrishnan, Ranjit Mohan Anjana, Viswanathan Mohan, Gopi Sundaramoorthy, Babu Kavitha, Venkatesan Radha, Colin G. NicholsPancreatic β-cell ATP-sensitive K+ (KATP) channel closure underlies electrical excitability and insulin release, but loss or inhibition of KATP channels can lead to paradoxical crossover from hyperinsulinism plus hypoglycemia, to glucose intolerance or diabetes. We report genotype-phenotype information from a set of patients clinically diagnosed with maturity-onset diabetes of the young (MODY) and
-
Analysis of multiple insulin actions in single muscle fibres from insulin resistant mice reveals selective defect in endogenous GLUT4 translocation Diabetes (IF 6.2) Pub Date : 2025-05-07
Sebastian Judge, Stewart WC Masson, Søren Madsen, Meg Potter, David E James, James G Burchfield, Alexis Diaz-VegasAccurate measurement of GLUT4 translocation is crucial for understanding insulin resistance in skeletal muscle, a key factor in the development of metabolic diseases. However, current methods rely on overexpressed epitope-tagged GLUT4 constructs or indirect measurements, limiting their physiological relevance and applicability. To overcome these challenges, we developed an innovative high-sensitivity
-
GENETIC VARIATION IN GCKR AND PNPLA3 REGULATE METABOLIC BALANCE ACROSS THE LIVER Diabetes (IF 6.2) Pub Date : 2025-05-07
Yunyun Ma, Shiqi Zuo, Therlinder Lo, David Phan, Tyler Finley, Adrienne Mackay, Enrique Trigo, Jaana A. Hartiala, Hooman Allayee, Anny H. Xiang, Thomas A. Buchanan, Richard M. WatanabeWe tested genetic variants in GCK, GCKR, and PNPLA3 for association with type 2 diabetes-related phenotypes under the hypothesis they may regulate metabolic balance across the liver and contribute to hepatic steatosis and insulin resistance in a large sample of self-identified Mexican Americans from the BetaGene Study. We further tested whether interactions with dietary fructose and total sugar contributes
-
Targeting tsRNA-1797 alleviates diabetes-induced vascular dysfunction through modulating purine metabolism Diabetes (IF 6.2) Pub Date : 2025-05-07
Duo Li, Jingyue Zhang, Xiaoyan Han, Lingjie Kong, Ying Zhang, Mudi Yao, Ling Ren, Wan Mu, Qin Jiang, Biao YanDiabetes is a metabolic disorder associated with an increased risk of systemic vascular complications. Notably, diabetic retinopathy (DR) represents a major microvascular complication and a leading cause of blindness and vision impairment. Despite its clinical significance, the precise molecular mechanisms underlying vascular dysfunction and the associated metabolic disturbances in DR remain incompletely
-
Identifying four obesity axes through integrative multi-omics and imaging analysis Diabetes (IF 6.2) Pub Date : 2025-05-07
Chiemela S. Odoemelam, Afreen Naz, Marjola Thanaj, Elena P Sorokin, Brandon Whitcher, Naveed Sattar, Jimmy D Bell, E Louise Thomas, Madeleine Cule, Hanieh YaghootkarWe aimed to identify distinct axes of obesity using advanced MRI-derived phenotypes. We used 24 MRI-derived fat distribution and muscle volume measures (UK Biobank, n= 33,122) to construct obesity axes through principal component analysis (PCA). Genome-wide association studies were performed for each axis to uncover genetic factors, followed by pathway enrichment, genetic correlation, and Mendelian
-
Advances in Cell Replacement Therapies for Diabetes Diabetes (IF 6.2) Pub Date : 2025-05-07
Bernhard J. Hering, Michael R. Rickels, Melena D. Bellin, Jeffrey R. Millman, Alice A. Tomei, Andrés J. García, Haval Shirwan, Cherie L. Stabler, Minglin Ma, Peng Yi, Xunrong Luo, Qizhi Tang, Sabarinathan Ramachandran, Jose Oberholzer, Camillo Ricordi, Timothy J. Kieffer, A.M. James ShapiroIslet cell replacement therapies have evolved as a viable treatment option for type 1 diabetes complicated by problematic hypoglycemia and glycemic lability. Refinements of islet manufacturing, islet transplantation procedures, peritransplant recipient management, and immunosuppressive protocols allowed most recipients to achieve favorable outcomes. Subsequent phase 3 trials of transplantation of deceased
-
Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human Islet Research Network (HIRN) Initiative Diabetes (IF 6.2) Pub Date : 2025-05-07
Audrey V. Parent, Ashutosh Agarwal, Juan Rene Alvarez-Dominguez, Rafael Arrojo e Drigo, Mark A. Atkinson, Michael A. Brehm, Leonardo M.R. Ferreira, Klaus H. Kaestner, Vira Kravets, Joyce C. Niland, Denis O’Meally, Layla Rouse, Holger A. Russ, Cherie L. Stabler, John S. KaddisThe identification of a “rundlichen Häuflein” by Paul Langerhans more than 150 years ago marked the initiation of a global effort to unravel the mysteries of pancreatic islets, an intricate system of nutrient-sensing, hormone-secreting, and signaling cells. In type 1 diabetes, this interconnected network is vulnerable to malfunction and immune attack, with strategies to prevent or repair islet damage
-
The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type 1 Versus Type 2 Diabetes Diabetes (IF 6.2) Pub Date : 2025-05-07
Teresa L.Z. Jones, Irina Kusmartseva, Silvio Litovsky, Rahul Thakar, Amanda L. Posgai, Robert H. Eckel, Mark A. AtkinsonCardiovascular disease (CVD) is a leading cause of morbidity and mortality in individuals with diabetes. Individuals with type 1 diabetes have a two- to fourfold higher risk of CVD in comparison with the general population, driven by an earlier onset and increased lifetime incidence of CVD events and mortality. Similarly, type 2 diabetes confers two- to threefold increased CVD risk, usually alongside
-
Celebrating the Past, Present, and Future of NIDDK-Supported Research Centers Focused on Diabetes, Endocrinology, and Metabolic Diseases Diabetes (IF 6.2) Pub Date : 2025-05-07
Corinne M. Silva, Pamela L. Thornton, Shavon Artis Dickerson, Thomas L. Eggerman, Maren R. Laughlin, Julie A. Wallace, Mary C. Hanlon-Tilghman, William T. CefaluThis year marks the 75th anniversary of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. NIDDK’s long history of research and innovation includes support of four types of collaborative research centers focused on diabetes, endocrinology, and metabolic diseases. The Diabetes Research Centers promote basic and clinical diabetes research
-
G protein-coupled receptor 35 suppresses oxidative stress response 1 in diabetic wound healing Diabetes (IF 6.2) Pub Date : 2025-05-07
Hainan Li, Liping Xu, Sai Pranathi Meda Venkata, Morgan Minjares, Hassan Melhem, Anjaneyulu Kowluru, Jan Hendrik Niess, Graeme Milligan, Jie-Mei WangG protein-coupled receptor 35 (GPR35) is a poorly characterized receptor with unclear intracellular mechanisms in endothelial cells (ECs). Oxidative stress responsive 1 (OXSR1) is a serine/ threonine protein kinase that modulates cell morphology and has recently been found to promote angiogenesis. We hypothesized that GPR35 inhibition promotes EC angiogenesis via augmenting OXSR1 activity and accelerating
-
The Normal 93: Linking the β-Cell and Insulin Sensitivity: Revisiting a 1993 Diabetes Classic by Kahn et al. Diabetes (IF 6.2) Pub Date : 2025-05-07
David D’Alessio, Steven E. KahnIn this month’s Classics in Diabetes featured article, published in Diabetes in 1993, the description by Kahn et al. of the relationship between insulin secretion and insulin sensitivity in 93 healthy adults without diabetes provided a model for the regulation of glucose tolerance that continues to be used today. In the study, data from a large sample of individuals studied with intravenous glucose
-
Neuroprotective Effect of a Novel Soluble Guanylate Cyclase Activator (sGCa) Runcaciguat in Diabetes and Ischemic Retinopathy Diabetes (IF 6.2) Pub Date : 2025-05-07
Elia J. Duh, Zhenhua Xu, Hongkwan Cho, Shirley Wu, William Schubert, Carsten Terjung, Fabio Baschiera, Lingli Zhou, Lijuan Wu, Grace Lee, Yangyiran Xie, Qiaoyan Hui, James Guerra, Joseph Mertz, Khaled NassarOxidative stress has a major pathogenic role in diabetic retinopathy, and neuroretina dysfunction is recognized as an early and important problem. Soluble guanylate cyclase (sGC) has been implicated for its neuroprotective effects in the central nervous system, but its role in the retina remains unclear. Here we demonstrated expression of sGC subunits GUCY1A1 and GUCY1B1 in healthy human and rodent
-
GLP-1-mediated targeting of inflammation corrects obesogenic memory in male mice Diabetes (IF 6.2) Pub Date : 2025-04-11
Stéphane Léon, Julie Benoit, Samantha Clark, Philippe Zizzari, Bin Yang, Isabelle Dugail, Fatiha Merabtene, Karine Clement, Louise Eygret, Nathalie Dupuy, Jean-Christophe Delpech, Moïra Rossitto, Matthias Mack, Thierry Lesté-Lasserre, Brian Finan, Daniela Cota, Carmelo QuartaObesity-induced biological changes often persist after weight loss and are difficult to reverse, a phenomenon known as ‘obesogenic memory’. This enduring effect is associated with metabolic inflammation, particularly in adipose tissue. In this study, we characterise a mouse model of obesogenic memory and evaluate the efficacy of the unimolecular conjugate GLP-1/Dexa, which selectively and safely delivers
-
BAP1 suppresses white adipose tissue browning and thermogenesis through deubiquitinating KDM1B Diabetes (IF 6.2) Pub Date : 2025-04-10
Pengchao Wang, Jingbo Zhu, Liuye Yang, Yilong Wang, Minglu Liang, Fengcen Li, Ze Wang, Kaiyuan Liu, Mingfa Ai, Dazhu Li, Kai Huang, Meng DuObesity is a growing global health threat, and inducing browning of white adipose tissue (WAT) to increase energy expenditure has become an attractive strategy for treating obesity and related metabolic complications. BRCA1-associated protein 1 (BAP1), a ubiquitin C-terminal hydrolase (UCH) domain-containing deubiquitinase (DUB) expressed broadly across tissues, has previously been shown to play an
-
Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant Diabetes (IF 6.2) Pub Date : 2025-04-09
Silvia Torchio, Gabriel Siracusano, Federica Cuozzo, Valentina Zamarian, Silvia Pellegrini, Fabio Manenti, Riccardo Bonfanti, Giulio Frontino, Valeria Sordi, Raniero Chimienti, Lorenzo PiemontiWolfram Syndrome 1 (WS1) is a rare genetic disorder caused by WFS1 variants that disrupt Wolframin, an endoplasmic reticulum-associated protein essential for cellular stress responses, Ca2+ homeostasis, and autophagy. Here, we investigated how the c.316-1G>A and c.757A>T WFS1 mutations, which yield partially functional Wolframin, affect the molecular functions of β cells and explored the therapeutic
-
What is Gestational Diabetes – Really? Diabetes (IF 6.2) Pub Date : 2025-04-08
Thomas A. Buchanan, Anny H. Xiang, Kathleen A. Page, Richard M. WatanabeGestational diabetes mellitus (GDM) is one of the most common medical complications of pregnancy. It is generally defined as glucose intolerance with onset or first recognition during pregnancy. The pathogenesis of GDM has long been attributed to inadequate pancreatic β-cell compensation for the physiological insulin resistance of pregnancy. This defect is thought to resolve after pregnancy but become
-
Metabolic and paracrine heterogeneity of pancreatic glucagon-secreting α-cells Diabetes (IF 6.2) Pub Date : 2025-04-04
Haiqiang Dou, Caroline Miranda, Johan Tolö, Cristiano Santos, Rui Gao, Nikhil R. Gandasi, Thomas G. Hill, Lakshmi Kothegala, Andrei I. Tarasov, Quan Zhang, Patrik RorsmanBy stimulating hepatic glucose production, glucagon (released by islet α-cells) restores normal blood glucose levels when they fall below the normal range. We used optogenetics in conjunction with electrophysiology, [Ca2+]i imaging and hormone release measurements to explore the intrinsic and paracrine regulation of glucagon secretion. Many α-cells were spontaneously active at 1mM glucose. However
-
Are polymorphisms within the fructosamine-3-kinase gene associated with the discordance between HbA1c and other measures of glycaemia? Diabetes (IF 6.2) Pub Date : 2025-04-04
Dipuo D. Motshwari, Cindy George, Elvis N. Ngwa, Annalise E. Zemlin, Andre P. Kengne, Glenda M. Davison, Rajiv T. Erasmus, Tandi E. MatshaGlycated haemoglobin (HbA1c) has shown disagreements with other glycaemic indices; termed the glycation gap. The glycation gap can be influenced by non-glycaemic factors like protein deglycation, through the fructosamine 3 kinase (FN3K) enzyme. This cross-sectional study aimed to examine whether single nucleotide polymorphisms (SNPs) in the FN3K gene can explain the glycation gap. Amongst the 826 participants
-
Surface Modification of Islets with L-DOPA-KF7 Enhances Islet Survival by Inhibiting IBMIR in Intrahepatic Islet Transplantation Diabetes (IF 6.2) Pub Date : 2025-04-04
Daopeng Yang, Bin Qiao, Fang Bai, Jinliang Duan, Haibin Ji, Xue Ma, Zepeng Lin, Yibo Hou, Xiaoshun He, Xiaofeng Zhu, Bowen Zhuang, Xiaoyan Xie, Anbin HuIntrahepatic islet transplantation is followed by islet loss due to instant blood-mediated inflammatory response (IBMIR), in which platelet activation plays a key role. The KEATSTF-fragment (KF7), a newly discovered platelet inhibitor that interferes with the formation of the 14-3-3z–c-Src–integrin-β3 complex, holds significant potential in inhibiting IBMIR without causing significant bleeding. This
-
miR-214 and its primary transcript Dnm3os regulate fibrosis and inflammation through RAGE signalling in diabetic kidney disease Diabetes (IF 6.2) Pub Date : 2025-04-04
Shinji Hagiwara, Jun Okabe, Mark Ziemann, Brian Drew, Maki Murakoshi, Karly C Sourris, Aaron D McClelland, Madhura Bose, Elif Ilhan Ekinci, Melinda Coughlan, Adrienne Laskowski, Hiroko Sakuma, Tomohito Gohda, Yusuke Suzuki, Mark E Cooper, Phillip KantharidisPathological signaling via the receptor for advanced glycation end-products (RAGE) is critical in diabetic kidney disease (DKD) development, while RAGE deletion is reno-protective. Non-coding RNAs (ncRNAs), including microRNAs (miRs), also play key roles in DKD, including renal fibrosis. However, the involvement of ncRNAs in RAGE signaling remains unclear. This study investigated the regulation of
-
The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes Diabetes (IF 6.2) Pub Date : 2025-04-02
Heba M Ismail, David Cuthbertson, Alfonso Galderisi, Ingrid Libman, Laura Jacobsen, Antoinette Moran, Alessandra Petrelli, Mark Atkinson, Maria J. Redondo, Tamara Hannon, Kieren J Mather, Jay M. SosenkoSince little is known about the disposition index (DI) in autoantibody-positive individuals, we have assessed whether DI has a similar association between insulin secretion and resistance to the association observed in other populations. In TrialNet Pathway to Prevention (TNPTP; n=6620) and Diabetes Prevention Trial-Type 1 (DPT-1; n=704) study participants, two secretion-sensitivity pairs each representing
-
A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes Diabetes (IF 6.2) Pub Date : 2025-04-02
Anika Bilal, Anna Casu, Fanchao Yi, Tumpa Dutta, Justine M. Mucinski, Gina Mercouffer, Martin C. Marak, Marcus Hompesch, David Kelley, Richard E. PratleyActivation of GPR119 receptors, expressed on enteroendocrine and pancreatic islet cells, augments glucagon counterregulatory responses to hypoglycemia in pre-clinical models. We hypothesized that MBX-2982, a GPR119 agonist, would augment counterregulatory responses to experimental hypoglycemia in participants with type 1 diabetes. To assess this, we designed a phase 2a double-masked, cross-over trial
-
DA-1241, a GPR119 agonist, ameliorates fatty liver through the upregulation of TFEB-mediated autophagy Diabetes (IF 6.2) Pub Date : 2025-03-28
Jin Yoo, Ji Eun Jun, In-Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung, Myung-Shik Lee, You-Cheol HwangG protein-coupled receptor 119 (GPR119) is predominantly expressed in pancreatic β-cells, enteroendocrine cells, and the liver. It is a novel therapeutic for dyslipidemia and type 2 diabetes. DA-1241, a GPR119 agonist, improves glucose tolerance by inhibiting gluconeogenesis and enhancing insulin secretion. It mitigates hepatic inflammation by inhibiting NFĸB signaling. However, the mechanism by which
-
Up-regulation of acid-sensing ion channel 1a in the anterior cingulate cortex by TNF-α/NF-κB pathway contributes to diabetes-related pain Diabetes (IF 6.2) Pub Date : 2025-03-25
Aijun Jiang, Hongrui Wei, Sijia Chu, Mengyuan Wang, Jinling Yan, Xing-Lei Song, Tian-Le Xu, Zhi Zhang, Yan Jin, Wei WangEffective treatment strategies for diabetes-related pain are limited due to its complex pathogenesis, particularly brain mechanisms underlying this disease. The acid-sensing ion channel 1a (ASIC1a) emerges as a key player in the development and treatment of various types of pain. Here, we investigated the role of ASIC1a in diabetes-related pain and its molecular mechanisms in the anterior cingulate
-
A Special Thanks to the Reviewers of Diabetes Diabetes (IF 6.2) Pub Date : 2025-03-20
Diabetes calls on thousands of scientific and medical experts each year to review manuscript submissions. The editors of Diabetes sincerely appreciate the efforts of all of our reviewers who volunteer their time and expertise to provide valuable feedback to ensure the consistently high quality of the research published in each issue. We would like to recognize the “top” reviewers—based on the number
-
Hepatic PKA Mediates the Liver and Pancreatic Alpha-Cell Crosstalk Diabetes (IF 6.2) Pub Date : 2025-03-17
Kehan Bao, Jason Berger, Erqian Na, Qi Su, Gabor Halasz, Mark Sleeman, Haruka OkamotoGlucagon stimulates hepatic glucose production, in part by promoting the uptake and catabolism of amino acids. Inhibition of liver glucagon receptor (GCGR) results in elevated plasma amino acids, which triggers the proliferation of pancreatic alpha-cells, forming a liver-alpha cell loop. This study aims to delineate hepatic signaling molecules downstream of GCGR which mediate the liver-alpha cell loop
-
Cardioprotection during myocardial infarction in diabetic cardiomyopathy Diabetes (IF 6.2) Pub Date : 2025-03-13
Sebastià Alcover, Sergi López, Lisaidy Ramos, Natàlia Muñoz-García, Alex Gallinat, Rosa Suades, Lina Badimon, Gemma VilahurDiabetic patients are at an increased risk of diabetic cardiomyopathy (DCM) and acute myocardial infarction (AMI). Protecting the heart against AMI is more challenging in DCM than non-diabetic hearts. We investigated whether intravenous atorvastatin administration during AMI exerts cardioprotection in DCM as seen in non-diabetic hearts. Sprague-Dawley rats were divided into streptozotocin-induced DCM
-
Novel cell-to-cell communications between macrophages and fibroblasts regulate obesity-induced adipose tissue fibrosis Diabetes (IF 6.2) Pub Date : 2025-03-10
Hiro Kohda, Miyako Tanaka, Shigeyuki Shichino, Satoko Arakawa, Tadasuke Komori, Ayaka Ito, Eri Wada, Kozue Ochi, Xunmei Yuan, Takehiko Takeda, Atsuhito Saiki, Ichiro Tatsuno, Kenji Ikeda, Yuki Miyai, Atsushi Enomoto, Yoshihiro Morikawa, Shigeomi Shimizu, Satoshi Ueha, Kouji Matsushima, Yoshihiro Ogawa, Takayoshi SuganamiRecent evidence has shown that adipose tissue eventually develops fibrosis through complex cellular crosstalk. Although advances in single-cell transcriptomics have provided new insights into cell diversity during this process, little is known about the interactions among the distinct cell types. In this study, we employed single-cell analytical approaches to investigate cell-tocell communications
-
Soluble HLA class I is released from human β-cells following exposure to interferons Diabetes (IF 6.2) Pub Date : 2025-03-10
Pouria Akhbari, Javier Perez-Hernandez, Mark A. Russell, Shalinee Dhayal, K. Afi Leslie, Stephanie L. Hunter, Kathryn Murrall, Alexia Carré, Noel G. Morgan, Roberto Mallone, Sarah J. RichardsonHLA class I (HLA-I) molecules present intracellular antigenic peptides to CD8+ T lymphocytes during immune surveillance. In donors with type 1 diabetes, hyperexpression of HLA-I occurs in islets with residual insulin-producing β-cells as a hallmark of the disease. HLA-I hyperexpression is frequently detected beyond the islet boundary, forming a ‘halo’. We hypothesized that this halo may reflect the
-
Reduced function of the adaptor SH2B3 promotes T1D via altered cytokine-regulated, T cell intrinsic immune tolerance Diabetes (IF 6.2) Pub Date : 2025-03-06
Taylor K. Watson, Aaron B.I. Rosen, Travis Drow, Jacob A. Medjo, Matthew A. MacQuivey, Yan Ge, H. Denny Liggitt, Dane A. Grosvenor, Kimberly A. Dill-McFarland, Matthew C. Altman, Patrick J. Concannon, Jane H. Buckner, David J. Rawlings, Eric J. AllenspachGenome-wide association studies have identified SH2B3 as an important non-MHC gene for islet autoimmunity and type 1 diabetes (T1D). In this study, we found a single SH2B3 haplotype significantly associated with increased risk for human T1D. Fine mapping has demonstrated the most credible causative variant is the single nucleotide rs3184504*T polymorphism in SH2B3. To better characterize the role of
-
Association of plasma angiogenin with risk of incident end-stage kidney disease in individuals with type 2 diabetes Diabetes (IF 6.2) Pub Date : 2025-03-04
Resham L Gurung, Jian-Jun Liu, Sylvia Liu, Janus Lee, Huili Zheng, Clara Chan, Keven Ang, Su Chi LimWe aim to investigate the association between plasma angiogenin and the risk of progression to end-stage kidney disease (ESKD) in Type 2 Diabetes (T2D) patients and attempted to infer the causal relationship between plasma angiogenin and chronic kidney disease. A total of 1863 outpatients with T2D were included in this prospective cohort study. ESKD was defined as a composite of progression to sustained
-
Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices Enables Physiological Insulin Delivery Dynamics Diabetes (IF 6.2) Pub Date : 2025-03-03
Ella A. Thomson, Sooyeon Lee, Haixia Xu, Hannah Moeller, Joanna Sands, Rayhan A. Lal, Justin P. Annes, Ada S. Y. PoonCadaveric islet and stem cell-derived transplantation hold promise as treatments for type 1 diabetes (T1D). To tackle the issue of immunocompatibility, numerous cellular macroencapsulation techniques that utilize diffusion to transport insulin across an immunoisolating barrier have been developed. However, despite several devices progressing to human clinical trials, none have successfully attained
-
Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel Glucagon Regulator Nidogen-2 Diabetes (IF 6.2) Pub Date : 2025-03-03
Jeongmin Lee, Alessandro Ustione, Emily M Wilkerson, Rekha Balakrishnan, Debbie C. Thurmond, Dennis Goldfarb, David W. PistonCurrent treatments for type 1 diabetes (T1D) focus on insulin replacement. We demonstrate the therapeutic potential of a secreted protein fraction from embryonic brown adipose tissue (BAT) that mediates insulin receptor-dependent recovery of euglycemia in a T1D model, nonobese diabetic (NOD) mice, by suppressing glucagon secretion. This fraction promotes white adipocyte differentiation and browning
-
Antihypertensive drug amlodipine besylate shows potential in alleviating diabetic peripheral neuropathy Diabetes (IF 6.2) Pub Date : 2025-02-28
Yuxi Wei, Yujie Huang, Runzhi Huang, Yuan Ruan, Tian Feng, Fan Zhou, Wei Zhang, Jianyu Lu, Sujie Xie, Yuntao Yao, Jiaying Wang, Shizhao Ji, Xu ShenDiabetic peripheral neuropathy (DPN) is a common diabetic complication with no currently available curative treatments. Here, we demonstrated that the protein level of G-protein-coupled receptor 40 (GPR40) is significantly repressed in the sciatic nerves (SN) of DPN patients, as well as in the peripheral nerves, including dorsal root ganglia (DRG) and SN, of streptozotocin (STZ)-induced type 1 diabetic
-
Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G Diabetes (IF 6.2) Pub Date : 2025-02-27
Shafeeq A. Mohammed, Era Gorica, Mattia Albiero, Gergely Karsai, Alessandro Mengozzi, Carlo Maria Caravaggi, Samuele Ambrosini, Stefano Masi, Maria Cristina Vinci, Omer Dzemali, Gaia Spinetti, Sanjay Rajagopalan, Assam El-Osta, Jaroslav Pelisek, Frank Ruschitzka, Gian Paolo Fadini, Sarah Costantino, Francesco PaneniRevascularization strategies failed to improve outcome in diabetic (DM) patients with peripheral artery disease (PAD). Histone modifications are key modulators of gene expression and could play a role in angiogenic response. This study investigates the role of chromatin remodelling in modulating angiogenesis in DM. RNA sequencing (RNA-seq) and angiogenic assays (cell migration and tube formation) were
-
Unilateral Primary Aldosteronism Lacking KCNJ5 Somatic Mutations is Associated with an Elevated Risk of New-Onset Diabetes Mellitus Diabetes (IF 6.2) Pub Date : 2025-02-25
Chieh-Kai Chan, Wei-Shiung Yang, Yen-Hung Lin, Vin-Cent Wu, Jeff S ChuehThe association between KCNJ5 mutations and the risk of developing new-onset diabetes mellitus (NODM) in patients with unilateral primary aldosteronism (uPA) remains underexplored. To investigate this association, we conducted a longitudinal study using data from the Taiwan Primary Aldosteronism Investigation database. Our sample included 360 uPA patients with adrenalectomies between 2012 and 2017
-
Metabolic dysfunction associated with alterations in gut microbiota in adolescents with obesity Diabetes (IF 6.2) Pub Date : 2025-02-21
Quin Yuhui Xie, Alessandra Granato, Anthony Wong, Christopher Yau, Rebecca Noseworthy, Tina Chen, Connor Gianetto-Hill, Emma Allen-Vercoe, Cynthia J. Guidos, Jill K. Hamilton, Jayne S. DanskaObesity in childhood is associated with adulthood obesity, type 2 diabetes (T2D), and future metabolic complications. The gut microbiome is a modifier of host metabolic function with altered bacterial composition associated with disease risk. Few studies have investigated the relationships between metabolic disease, inflammation and the gut microbiota in youth where these connections likely originate
-
Development of the Insulin Radioimmunoassay, the Watershed Moment in Diabetes Research: Revisiting 1960 Diabetes Classics by Berson and Yalow Diabetes (IF 6.2) Pub Date : 2025-02-20
David A. D’AlessioThe discovery and development of the radioimmunoassay (RIA) for insulin by Berson and Yalow fundamentally changed biomedical science. The story of this accomplishment began with the pairing of brilliant scientists with complementary expertise who identified a key gap in knowledge they were able to bridge through a series of insightful experiments. Through a succession of important publications over
-
CD40 INDUCES UNFOLDED PROTEIN RESPONSE, UPREGULATION OF VEGF AND VASCULAR LEAKAGE IN DIABETIC RETINOPATHY Diabetes (IF 6.2) Pub Date : 2025-02-20
Sarah Vos, Jose-Andres C. Portillo, Alyssa Hubal, Reena Bapputty, Amelia Pfaff, Rachel Aaron, Matthew Weng, Da Sun, Zheng-Rong Lu, Jin-Sang Yu, Carlos S. SubausteThe unfolded protein response (UPR) drives events that promote diabetic retinopathy including VEGF upregulation in Müller cells. How UPR is activated in vivo in the diabetic retina is not well understood. CD40 is required for development of diabetic retinopathy but whether CD40 mediates activation of UPR sensors is unknown. CD40 ligation in Müller cells caused phospholipase Cγ1 (PLCγ1)-dependent activation
-
Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons Diabetes (IF 6.2) Pub Date : 2025-02-20
Muhammad Saad Yousuf, Marisol Mancilla Moreno, Brodie J Woodall, Vikram Thakur, Jiahe Li, Lucy He, Rohita Arjarapu, Danielle Royer, Jennifer Zhang, Munmun Chattopadhyay, Peter M Grace, Theodore J PriceDiabetic neuropathic pain is associated with elevated plasma levels of methylglyoxal (MGO). MGO is a metabolite of glycolysis that causes pain hypersensitivity in mice by stimulating the phosphorylation of eukaryotic initiation factor 2α (p-eIF2α) and subsequently activating the integrated stress response (ISR). We first established that Zucker Diabetic Fatty (ZDF) rats have enhanced MGO signaling
-
Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism Diabetes (IF 6.2) Pub Date : 2025-02-13
Mattia Albiero, Ludovica Migliozzi, Carlotta Boscaro, Anna Rodella, Stefano Ciciliot, Francesco Ivan Amendolagine, Valentina Scattolini, Laura Treu, Roberta Cappellari, Paola Lanuti, Annica Barizza, Gaia Codolo, Alessandra Giannella, Giulio Ceolotto, Tatiana Varanita, Luca Prevedello, Mirto Foletto, Sara Bogialli, Stefano Campanaro, Angelo Avogaro, Gian Paolo FadiniMicrobial signals trigger the release of neutrophil extracellular traps (NETs) through peptidyl-arginine-deiminase-4 (PADI4). In turn, NETosis can propagate inflammation to distant tissues. We hypothesize that PADI4 mediates the interactions between diet-modified microbiota and host metabolism. We report that in the adipose tissue of individuals with obesity, NETosis was associated with dysglycemia
-
Differential Effects of Retinol-Binding Protein 3 and Anti-VEGF Antibodies on Retinal Dysfunctions in Diabetic Retinopathy Diabetes (IF 6.2) Pub Date : 2025-02-12
Qin Li, Satoru Onizuka, Kyoungmin Park, Mingming Ma, Ward Fickweiler, Hyunseok Park, Qian Li, Fabricio Simao, Jared Boisclair, Maha Sharawy, I-Hsien Wu, Marc Gregory Yu, Lloyd P. Aiello, Jennifer K. Sun, George L. KingAnti-vascular endothelial growth factor (anti-VEGF) therapies are effective treatment of severe diabetic retinopathy (DR) and macular edema, but a significant subset of people showed inadequate response to anti-VEGF intervention. Since elevation or overexpressing retinol binding protein 3 (RBP3) decreased risks for retinal pathologies and progression to severe DR, we compared the therapeutic profile
-
Canagliflozin-induced adaptive metabolism in bone Diabetes (IF 6.2) Pub Date : 2025-02-11
Sher Bahadur Poudel, Carolyn Chlebek, Ryan R. Ruff, Zhiming He, Fangxi Xu, Gozde Yildirim, Bin Hu, Christopher Lawrence De Jesus, Ankita Raja Shinde, Vasudev Vivekanand Nayak, Lukasz Witek, Timothy Bromage, Thomas A Neubert, Clifford J Rosen, Shoshana YakarSodium-glucose transporter-2 inhibitor (SGLT2i) drugs are widely used for lowering blood glucose levels independent of insulin. Beyond this, these drugs induce various metabolic changes, including weight loss and impaired bone integrity. There is a significant gap in understanding SGLT2i-induced skeletal changes, as SGLT2 is not expressed in osteoblasts or osteocytes, which use glucose to remodel the
-
Comparison of the Effects of SGLT-2i versus GLP-1RA on Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus based on Baseline Renal Function Diabetes (IF 6.2) Pub Date : 2025-02-11
Yu Wang, Chao Xia, Manna Li, Gaosi XuThere remained no head-to-head research to evaluate the cardiovascular and renal benefits of sodium-glucose cotransporter 2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in patients with type 2 diabetes mellitus (T2DM) at different baseline renal function. We performed a network meta-analysis to compare the two drugs indirectly. Systematic literature searches were conducted
-
Lrtm1 - A Novel Sensor of Insulin Signaling and Regulator of Metabolism and Activity Diabetes (IF 6.2) Pub Date : 2025-02-07
Yingying Yu, Guoxiao Wang, Wenqiang Chen, Xiangyu Liu, Vitor Rosetto Munoz, Weikang Cai, Antonio S. Gomes, C. Ronald KahnInsulin regulates glucose uptake and metabolism in muscle via the insulin receptor. Here we show that Lrtm1 (Leucine Rich Repeats and Transmembrane Domains 1), a protein of unknown function enriched in insulin-responsive metabolic tissues, senses changes in insulin signaling in muscle and serves as a regulator of metabolic response. Thus, whole-body Lrtm1 deficient mice exhibit a reduced the percentage
-
Atf4 protects islet β-cell identity and function under acute glucose-induced stress but promotes β-cell failure in the presence of free fatty acid Diabetes (IF 6.2) Pub Date : 2025-02-03
Mahircan Yagan, Sadia Najam, Ruiying Hu, Yu Wang, Mathew Dickerson, Prasanna Dadi, Yanwen Xu, Alan J. Simmons, Roland Stein, Christopher M. Adams, David A. Jacobson, Ken S. Lau, Qi Liu, Guoqiang GuGlucolipotoxicity, caused by combined hyperglycemia and hyperlipidemia, results in β-cell failure and type 2 diabetes via cellular stress-related mechanisms. Activating transcription factor 4 (Atf4) is an essential effector of stress response. We show here that Atf4 expression in β-cells is minimally required for glucose homeostasis in juvenile and adolescent mice but it is needed for β-cell function
-
Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ Diabetes (IF 6.2) Pub Date : 2025-01-28
Shu Yang, Lijiao Xiong, Tingfeng Liao, Lixing Li, Yanchun Li, Lin Kang, Guangyan Yang, Zhen LiangInsulin resistance, a hallmark of type 2 diabetes, accelerates muscle breakdown and impairs energy metabolism. However, the role of Ubiquitin Specific Peptidase 2 (USP2), a key regulator of insulin resistance, in sarcopenia remains unclear. Peroxisome proliferator activated receptor γ (PPARγ) plays a critical role in regulating muscle atrophy. This study investigates the role of deubiquitinase USP2
-
Identification of CD209 as an Intervention Target for Type 2 Diabetes after COVID-19 Infection: Insights from Proteome-wide Mendelian Randomization Diabetes (IF 6.2) Pub Date : 2025-01-28
Jiaying Zhang, Feng Jiao, Zhenqian Wang, Chenfeng Zou, Xiangjun Du, Dewei Ye, Guozhi JiangIncreasing evidence suggests that individuals infected with Coronavirus disease 2019 (COVID-19) are at a higher risk of developing type 2 diabetes (T2D) compared to those who are not infected. However, the mechanisms underlying this relationship remain poorly understood. In this study, we aimed to systematically evaluate the mediating roles of 3,283 plasma proteins in the link between COVID-19 susceptibility
-
An alternatively translated isoform of PPARG proposes AF-1 domain inhibition as an insulin sensitization target Diabetes (IF 6.2) Pub Date : 2025-01-24
Xiaomi Du, Karen Mendez-Lara, Siqi Hu, Rachel Diao, Guru Bhavimani, Ruben Hernandez, Kimberly Glass, Camila De Arruda Saldanha, Jason Flannick, Sven Heinz, Amit R. MajithiaPPARγ is the pharmacological target of thiazolidinediones (TZDs), potent insulin sensitizers that prevent metabolic disease morbidity but are accompanied by side effects such as weight gain, in part due to non-physiological transcriptional agonism. Using high throughput genome engineering, we targeted nonsense mutations to every exon of PPARG, finding an ATG in Exon 2 (chr3:12381414, CCDS2609 c.A403)
-
Extracellular vesicle-associated miR-ERIA exerts the anti-angiogenic effect of macrophages in diabetic wound healing Diabetes (IF 6.2) Pub Date : 2025-01-24
Tingting Zeng, Kan Sun, Lifang Mai, Xiaosi Hong, Xiaodan He, Weijie Lin, Sifan Chen, Li YanMany cell types are involved in the regulation of cutaneous wound healing in diabetes. Clarifying the mechanism of cell-cell interactions is important for identifying therapeutic targets for diabetic cutaneous ulcers. The function of vascular endothelial cells in the cutaneous microenvironment is critical, and a decrease in their biological function leads directly to refractory wound healing. In this
-
Homeobox C4 transcription factor promotes adipose tissue thermogenesis Diabetes (IF 6.2) Pub Date : 2025-01-24
Ting Yang, Yuxuan Wang, Hang Li, Fengshou Shi, Siqi Xu, Yingting Wu, Jiaqi Xin, Yi Liu, Mengxi JiangThe homeobox (HOX) family has shown potential in adipose development and function, yet the specific HOX proteins fueling adipose thermogenesis remain elusive. In this study, we uncovered the novel function of HOXC4 in stimulating adipose thermogenesis. Our bioinformatic analysis indicated an enrichment of Hoxc4 co-expressed genes in metabolic pathways and linked HOXC4 polymorphisms to metabolic parameters
-
Mechanistic Insights Into the Exercise-Induced Changes in Muscle Lipids and Insulin Sensitivity—Expanding on the “Athlete’s Paradox”: Revisiting a 2011 Diabetes Classic by Amati et al. Diabetes (IF 6.2) Pub Date : 2025-01-21
Jeffrey F. Horowitz, Bret H. GoodpasterEndurance exercise is widely recognized for its role in mitigating insulin resistance, yet the precise mechanisms remain unclear. In this Classics in Diabetes article, we revisit the article by Amati et al., “Skeletal Muscle Triglycerides, Diacylglycerols, and Ceramides in Insulin Resistance: Another Paradox in Endurance-Trained Athletes?” Published in the October 2011 issue of Diabetes, this article
-
A new model of experimental diabetic cardiomyopathy using combination of multiple doses of anomer-equilibrated streptozotocin and high fat diet: sex matters. Diabetes (IF 6.2) Pub Date : 2025-01-21
Loucia Karatzia, Fenn Cullen, Megan Young, Shing Hei Lam, Valle Morales, Katiuscia Bianchi, Sian M. Henson, Dunja AksentijevicDiabetes mellitus (DM) leads to a more rapid development of DM cardiomyopathy (dbCM) and progression to heart failure in women than men. Combination of high-fat diet (HFD) and freshly-injected streptozotocin (STZ) has been widely used for DM induction, however emerging data shows that anomer-equilibrated STZ produces an early onset and robust DM model. We designed a novel protocol utilising a combination
-
Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects Diabetes (IF 6.2) Pub Date : 2025-01-16
Anita C. Hohenstein, Joylynn Gallegos, Mylinh Dang, Jason Groegler, Hali Broncucia, Fatima Tensun, Kathleen Waugh, Fran Dong, Eddie A. James, Cate Speake, Andrea K. Steck, Marian J. Rewers, Peter A. Gottlieb, Kathryn Haskins, Thomas Delong, Rocky L. BakerType 1 Diabetes (T1D) is an autoimmune disease mediated by autoreactive T cells. Our studies indicate that CD4 T cells reactive to Hybrid Insulin Peptides (HIPs) play a critical role in T cell-mediated beta-cell destruction. We have shown that HIPs form in human islets between fragments of the C-peptide and cleavage products of secretory granule proteins. To identify T cell specificities contributing